QuickView for bix 01294 (compound)

1. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
2. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
3. L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
4. L1000 CMAP - Neural progenitor NPC.CAS9 cells treated with small molecule perturbagens
5. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)

1. BIX-01294 enhances the effect of chemotherapy on colorectal cancer by inhibiting the expression of s…
2. BIX01294 inhibits EGFR signaling in EGFR-mutant lung adenocarcinoma cells through a BCKDHA-mediated …
3. BIX-01294, a G9a inhibitor, suppresses cell proliferation by inhibiting autophagic flux in nasophary…
4. BIX-01294 enhanced chemotherapy effect in gastric cancer by inducing GSDME-mediated pyroptosis.
5. Nicotinamide activates latent HIV-1 ex vivo in ART suppressed individuals, revealing higher potency …

There were no clinical trials for bix 01294